
Opinion|Videos|December 19, 2025
Economic Burden and Systemwide Strategies
Panelists discuss how the economic toll of poor LDL-C control demands workplace and systemwide prevention strategies.
Advertisement
Episodes in this series

Panelists discuss how poor low-density lipoprotein cholesterol (LDL-C) control imposes substantial economic costs through hospitalizations, lost productivity, and long-term treatment of cardiovascular events.
They highlight that preventive strategies—such as workplace screenings and wellness incentives—can improve early detection and reduce downstream costs.
Panelists conclude that systemwide coordination between employers, payers, and clinicians is necessary to make cholesterol control a sustainable public health priority.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Early Treatment Succeeds in CRC With Next Generation KRAS Inhibitor Calderasib Plus Cetuximab Combo
2
Tec-Dara Shows MRD-Negative, PFS Benefit in High-Risk Myeloma, But Longer Follow-Up Needed: Rahul Banerjee, MD
3
Real-World Data Show MASH Progresses Faster Than Trials Suggest
4
Adam Kittai, MD, on Sequencing, Cost, and the Road to CLL Cure
5





